NASDAQ · Health care

Lite Strategy, Inc. (LITS)

It posted a net loss of $60.8M. In fiscal 2025 capital spending exceeded operating cash flow by $20.8M. At March 31, 2026 it held $7.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 13, 2026.

Price

$1.44

+0.70% on the day · September 25, 2026

52-week range $0.69 to $2.97

Market cap

$49M

What Lite Strategy, Inc. does

Lite Strategy, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker LITS.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$0	-$17.5M	-$15.9M	-$2.39	-$20.8M
2024	$65.3M	$14.5M	$17.8M	$2.67	-$50.5M
2023	$48.8M	-$36.8M	-$32M	-$4.78	-$52.5M
2022	$40.7M	-$75.5M	-$54M	-$9.99	-$49.2M
2021	$34.8M	-$60.4M	-$41M	-$11.99	-$32.7M
2020	$27.8M	-$25.7M	-$47.2M	-$10.39	$33.4M

Full financial statements: income, balance sheet and cash flow

Next report expected around October 23, 2026.

Estimated from its filing rhythm: about 85 days after its last report of July 30, 2026, its usual gap. Not a date the company has announced. See the report calendar

Dividends

Fiscal year	Per share	Paid out	Of profit
2025	n/a	$0	n/a
2024	$1.75	$11.7M	66%
2023	n/a	$0	n/a

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Lite Strategy, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

August 3, 2026
Passive stake changed SCHEDULE 13G/A
July 30, 2026
Quarterly results 8-K
July 24, 2026
Investor disclosure 8-K
May 13, 2026
Quarterly results 8-K
May 13, 2026
Quarterly report 10-Q · period to March 31, 2026Diluted EPS -$0.66 versus -$0.39.
February 17, 2026
Passive stake changed SCHEDULE 13G/A
February 17, 2026
Quarterly results 8-K
February 17, 2026
Quarterly report 10-Q · period to December 31, 2025Diluted EPS -$0.82 versus -$0.40.
February 12, 2026
Executive or director change 8-K
January 27, 2026
Additional proxy material DEFA14A

Recent insider filings (Forms 3, 4 and 144): 10, the latest on June 25, 2026. Insider transactions on SEC

Insider trades

What the people running Lite Strategy, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)

last 90 days

Sold

last 90 days

Date	Insider	What	Shares	Price	Value	Filing
June 24, 2026	Flynn James PDirector	Bought	25,000	$0.86	$21.4K	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns LITS

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

No holder of 5% or more has filed about this company in that window.

Latest filings below 5%: Alexander Schornstein 0% (August 3, 2026); Kenneth Griffin 3.9% (February 17, 2026); The Vanguard Group 2% (October 31, 2025); Anson Funds Management LP 3.7% (July 24, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 125,000 shares in total, about $180K at the last price.

Holder	Shares	As of
Flynn James PDirector	125,000	June 24, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about LITS

What does Lite Strategy, Inc. do?

Lite Strategy, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker LITS.

Is Lite Strategy, Inc. profitable?

No. Over the twelve months to March 31, 2026 it reported a net loss of $60.8M.

When did Lite Strategy, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on May 13, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the passive stake changed from August 3, 2026.

Similar companies

Compare LITS with

Compare LITS with any company

Follow LITS

Get an email when Lite Strategy, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow LITS: get an email when it files

Where the numbers come from

Financial figures are the values Lite Strategy, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.